arrow
Back
G

Gerhardt Attard

university college london

88H-index
573Paper Count
3.5WCitation Count
Published Papers 195
Publication Date
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer
err2026-06-19
err0
errOAAI
errSirui Weng; Lachlan Cain; James Comben; Yangyi Zhang; Timothy Semple; Sara Alaei; David Yoannidis; Luciano Martelotto; Catherine Mitchell; Anupama Pasam; Richard J. Young; Benjamin Blyth; Joy Hendley; Yuzhou Feng; Heather Thorne; Roslyn Wallace; Joanna Chan; Julia Como; Lisa Devereux; Himisha Beltran; Daniel Wetterskog; Scott Williams; Anthony T. Papenfuss; Belinda Parker; Paul Neeson; Gerhardt Attard; David Quigley; David L. Goode; Richard B. Pearson; Luc Furic; Anna S. Trigos; Shahneen Sandhu
errShare
errSave
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study
err2026-05-15
err0
errOAAI
errAnuradha Jayaram; Memuna Rashid; Alison H. M. Reid; Francesco Orlando; Suparna Thakali; Leila Zakka; Miriam Goncalves; Jacqueline O’Dwyer; Constantine Alifrangis; Rob Jones; Elias Pintus; Sarah Needleman; Diletta Bianchini; Anna Wingate; Kenrick Ng; Mark Linch; Ursula McGovern; John Staffurth; Simon J. Crabb; Susannah Brock; Alison Birtle; Osvaldas Vainauskas; Gianmarco Leone; Millenn Chiwewe; Allan Hackshaw; Andre Lopes; Daniel Wetterskog; Francesca Demichelis; Gerhardt Attard
errShare
errSave
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
err2025-11-04
err0
PREAI
errIrbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce
errShare
errSave
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial
err2025-10-07
err0
errOAAI
errGerhardt Attard; Neeraj Agarwal; Julie N. Graff; Shahneen Sandhu; Eleni Efstathiou; Mustafa Özgüroğlu; Andrea J. Pereira de Santana Gomes; Karina Vianna; Hong Luo; Geoffrey T. Gotto; Heather H. Cheng; Won Kim; Carly R. Varela; Daneen Schaeffer; Kassie Kramer; Susan Li; Benoit Baron; Fei Shen; Suneel D. Mundle; Sharon A. McCarthy; David Olmos; Kim N. Chi; Dana E. Rathkopf
errShare
errSave
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers
errCell
IF42.5
err2025-08-26
err0
errOAAI
errEmily Grist; Peter Dutey-Magni; Marina A. Parry; Larissa Mendes; Ashwin Sachdeva; James A. Proudfoot; Anis A. Hamid; Mazlina Ismail; Sarah Howlett; Stefanie Friedrich; Lia DePaula Oliveira; Laura Murphy; Christopher Brawley; Oluwademilade Dairo; Sharanpreet Lall; Yang Liu; Daniel Wetterskog; Anna Wingate; Karolina Nowakowska; Leila Zakka; Claire L. Amos; Nafisah B. Atako; Victoria Wang; Hannah L. Rush; Robert J. Jones; Hing Leung; William R. Cross; Silke Gillessen; Chris C. Parker; Teresa Marafioti; Alfonso Urbanucci; Matthew Fittall; Edward M. Schaeffer; Daniel E. Spratt; David Waugh; Thomas Powles; Matthew R. Sydes; Felix Y. Feng; Daniel M. Berney; Mahesh K.B. Parmar; Noel W. Clarke; Elai Davicioni; Tamara L. Lotan; Christopher J. Sweeney; Louise C. Brown; Nicholas D. James; Gerhardt Attard
errShare
errSave
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer
err2025-07-19
err0
PREAI
errSoumyajit Roy; Yilun Sun; James A. Eastham; Martin Gleave; Christopher J.D. Wallis; Himisha A. Beltran; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Himanshu Nagar; Jorge A. Garcia; Eric J. Small; Paul Nguyen; Gerhardt Attard; Rana R. McKay; Oliver Sartor; Alejandro Berlin; Seth A. Rosenthal; Susan Halabi; Randy Vince; Lee Ponsky; Scott C. Morgan; Raquibul Hannan; Adam Raben; Mack Roach; Jeff M. Michalski; Michael J. Morris; Howard M. Sandler; Daniel E. Spratt
errShare
errSave
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial
err2025-07-17
err0
errOAAI
errRyan M. Phillips; James A. Proudfoot; Elai Davicioni; Yang Liu; Daniel E. Spratt; Jeff M. Simko; Robert B. Den; Alan Pollack; Seth A. Rosenthal; A. Oliver Sartor; Christopher J. Sweeney; Gerhardt Attard; Leslie Longoria; Samir Patel; Michael W. Straza; Jason A. Efstathiou; Amit B. Shah; Karen E. Hoffman; Joseph P. Rodgers; Howard M. Sandler; Felix Y. Feng; Phuoc T. Tran
errShare
errSave
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
err2025-07-07
err0
errOAAI
errSilke Gillessen; Laura Murphy; Nicholas D James; Ashwin Sachdeva; Omar El-Taji; Hoda Abdel-Aty; Amanda I Adler; Claire Amos; Gerhardt Attard; Mohini Varughese; Joanna Gale; Simon Brown; Narayanan Srihari; Alison J Birtle; Mick Brown; Kitty Chan; Simon Chowdhury; William Cross; David P Dearnaley; Omar Din; Peter Dutey-Magni; Duncan C Gilbert; Clare Gilson; Struan Gray; Emily Grist; Uschi Hofmann; Andrew M Hudson; Yatin Jain; Ganesan Jeyasangar; Robert Jones; Mahaz Kayani; Ruth E Langley; Zafar Malik; Malcolm D Mason; David Matheson; Connor McAlpine; Archie Macnair; Robin Millman; Claire Murphy; Minal Padden-Modi; Omi Parikh; Chris Parker; Hannah Rush; Martin Russell; Rajaguru Srinivasan; Santhanam Sundar; Jacob S Tanguay; Fabio Turco; Patrick Williams; Matthew R Sydes; Mahesh K B Parmar; Louise C Brown; Noel W Clarke
errShare
errSave
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol
err2025-06-01
err0
errOAAI
errCharles T A Parker; Larissa Mendes; Vinnie Y T Liu; Emily Grist; Songwan Joun; Rikiya Yamashita; Akinori Mitani; Emmalyn Chen; Marina A Parry; Ashwin Sachdeva; Laura Murphy; Huei-Chung Huang; Jacqueline Griffin; Douwe van der Wal; Tamara Todorovic; Sharanpreet Lall; Sara Santos Vidal; Miriam Goncalves; Suparna Thakali; Anna Wingate; Leila Zakka; Mick Brown; Daniel Wetterskog; Claire L Amos; Nafisah B Atako; Robert J Jones; William R Cross; Silke Gillessen; Chris C Parker; Daniel M Berney; Phuoc T Tran; Daniel E Spratt; Matthew R Sydes; Mahesh K B Parmar; Noel W Clarke; Louise C Brown; Felix Y Feng; Andre Esteva; Nicholas D James; Gerhardt Attard
errShare
errSave
Evaluating Cribriform Pattern with Clinical Outcomes in the STAMPEDE Cohort of Primary Advanced Hormone Sensitive Prostate Cancer
err2025-03-01
err0
PREAI
errMendes, Larissa; Dutey-Magni, Peter; Parker, Charles; Grist, Emily; Parry, Marina; Santos-Vidal, Sara; Lall, Sharanpreet; Haran, Aine; Hoyle, Alex; Parker, Christopher; Sydes, Mathew; Clarke, Noel; Brown, Louise; Parmar, Mahesh; James, Nicholas; Attard, Gerhardt; Berney, Daniel
errShare
errSave
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer
err2025-03-01
err0
errOAAI
errChi, Kim N.; Rathkopf, Dana; Smith, Matthew R.; Efstathiou, Eleni; Attard, Gerhardt; Olmos, David; Lee, Ji Youl; Small, Eric J.; Gomes, Andrea J. Pereira de Santana; Roubaud, Guilhem; Saad, Marniza; Zurawski, Bogdan; Sakalo, Valerii; Mason, Gary E.; Francis, Peter; Wang, George; Wu, Daphne; Diorio, Brooke; Lopez-Gitlitz, Angela; Sandhu, Shahneen
errShare
errSave
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial
err2025-02-01
err1
errOAAI
errRuiz-Vico, Maria; Wetterskog, Daniel; Orlando, Francesco; Thakali, Suparna; Wingate, Anna; Jayaram, Anuradha; Cremaschi, Paolo; Vainauskas, Osvaldas; Brighi, Nicole; Castellano-Gauna, Daniel; Astrom, Lennart; Matveev, Vsevolod B.; Bracarda, Sergio; Esen, Adil; Feyerabend, Susan; Senkus, Elzbieta; Piqueras, Marta Lopez-Brea; Gupta, Santosh; Wenstrup, Rick; Boysen, Gunther; Martins, Karla; Iwata, Kenneth; Chowdhury, Simon; Gourgioti, Georgia; Serikoff, Alexis; Gonzalez-Billalabeitia, Enrique; Merseburger, Axel S.; Demichelis, Francesca; Attard, Gerhardt
errShare
errSave
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer
err2025-02-01
err0
errOAAI
errAzad, Arun A.; Kostos, Louise; Agarwal, Neeraj; Attard, Gerhardt; Davis, Ian D.; Dorff, Tanya; Gillessen, Silke; Parker, Chris; Smith, Matthew R.; Sweeney, Christopher J.; Tombal, Bertrand; Fizazi, Karim
errShare
errSave
Digital Pathology–based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer
err2024-12-01
err0
PREAI
errMark C. Markowski; Yi Ren; Meghan Tierney; Trevor J. Royce; Rikiya Yamashita; Danielle Croucher; Huei-Chung Huang; Tamara Todorovic; Emmalyn Chen; Timothy N. Showalter; Michael A. Carducci; Yu-Hui Chen; Glenn Liu; Charles T.A. Parker; Andre Esteva; Felix Y. Feng; Gerhardt Attard; Christopher J. Sweeney
errShare
errSave
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer
err2024-11-16
err0
errOAAI
errKiviaho, Antti; Eerola, Sini K.; Kallio, Heini M. L.; Andersen, Maria K.; Hoikka, Miina; Tiihonen, Aliisa M.; Salonen, Iida; Spotbeen, Xander; Giesen, Alexander; Parker, Charles T. A.; Taavitsainen, Sinja; Hantula, Olli; Marttinen, Mikael; Hermelo, Ismail; Ismail, Mazlina; Midtbust, Elise; Wess, Maximilian; Devlies, Wout; Sharma, Abhibhav; Krossa, Sebastian; Hakkinen, Tomi; Afyounian, Ebrahim; Vandereyken, Katy; Kint, Sam; Kesseli, Juha; Tolonen, Teemu; Tammela, Teuvo L. J.; Viset, Trond; Storkersen, Oystein; Giskeodegard, Guro F.; Rye, Morten B.; Murtola, Teemu; Erickson, Andrew; Latonen, Leena; Bova, G. Steven; Mills, Ian G.; Joniau, Steven; Swinnen, Johannes V.; Voet, Thierry; Mirtti, Tuomas; Attard, Gerhardt; Claessens, Frank; Visakorpi, Tapio; Rautajoki, Kirsi J.; Tessem, May-Britt; Urbanucci, Alfonso; Nykter, Matti
errShare
errSave
Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial
err2024-09-23
err0
errOAAI
errDana E. Rathkopf; Guilhem Roubaud; Kim N. Chi; Eleni Efstathiou; Gerhardt Attard; David Olmos; Eric J. Small; Marniza Saad; Elena Castro; Won Kim; Daphne Wu; Kristi Bertzos; Shiva Dibaj; Jenny Zhang; Peter Francis; Matthew R. Smith
errShare
errSave
Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer
err2024-09-01
err1
PREAI
errRoubaud, Guilhem; Attard, Gerhardt; Boegemann, Martin; Olmos, David; Trevisan, Marco; Antoni, Laurent; Pascoe, Katie; Capone, Camille; Van Sanden, Suzy; Hashim, Mahmoud; Palmer, Stephen; Chi, Kim
errShare
errSave
Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials
err2024-09-01
err2
PREAI
errGrist, E.; Dutey-Magni, P.; Mendes, L.; Parry, M. A.; Sachdeva, A.; Proudfoot, J.; Hamid, A. A.; Amos, C. L.; Cross, W.; Gillessen, S.; Berney, D. M.; Sydes, M. R.; Parmar, M. K.; Feng, F.; Clarke, N.; Davicioni, E.; Sweeney, C.; James, N. D.; Brown, L. C.; Attard, G.
errShare
errSave